Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Imbert

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Biomedicines|June 1, 2017
NF-κB in Hematological MalignanciesVéronique Imbert, Jean-François Peyron
European Cytokine Network|September 17, 2002
Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sitesVéronique Imbert, Roger Rezzonico, Patrick Reichenbach, et al.
Cellular Signalling|June 22, 2005
Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survivalOlivia Cochet, Catherine Frelin, Jean-François Peyron, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|April 8, 2004
Monitoring NF-kappa B transactivation potential via real-time PCR quantification of I kappa B-alpha gene expressionVirginie Bottero, Véronique Imbert, Catherine Frelin, et al.
The EMBO Journal|December 24, 2004
NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell deathRaphaël Thyss, Virginie Virolle, Véronique Imbert, et al.
Oncogene|November 7, 2003
AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cellsCatherine Frelin, Véronique Imbert, Emmanuel Griessinger, et al.
Frontiers in Oncology|November 26, 2020
New Drug Repositioning Candidates for T-ALL Identified <i>Via</i> Human/Murine Gene Signature ComparisonRaphaël Bonnet, Marielle Nebout, Carine Brousse, et al.
Oncogene|June 26, 2002
Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effectorValère Busuttil, Virginie Bottero, Catherine Frelin, et al.
Nature Communications|September 27, 2016
Structure-function insights reveal the human ribosome as a cancer target for antibioticsAlexander G Myasnikov, S Kundhavai Natchiar, Marielle Nebout, et al.
Leukemia & Lymphoma|June 24, 2017
Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cellsVéronique Imbert, Marielle Nebout, Didier Mary, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Biomedicines|June 1, 2017
NF-κB in Hematological MalignanciesVéronique Imbert, Jean-François Peyron
European Cytokine Network|September 17, 2002
Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sitesVéronique Imbert, Roger Rezzonico, Patrick Reichenbach, et al.
Cellular Signalling|June 22, 2005
Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survivalOlivia Cochet, Catherine Frelin, Jean-François Peyron, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|April 8, 2004
Monitoring NF-kappa B transactivation potential via real-time PCR quantification of I kappa B-alpha gene expressionVirginie Bottero, Véronique Imbert, Catherine Frelin, et al.
The EMBO Journal|December 24, 2004
NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell deathRaphaël Thyss, Virginie Virolle, Véronique Imbert, et al.
Oncogene|November 7, 2003
AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cellsCatherine Frelin, Véronique Imbert, Emmanuel Griessinger, et al.
Frontiers in Oncology|November 26, 2020
New Drug Repositioning Candidates for T-ALL Identified <i>Via</i> Human/Murine Gene Signature ComparisonRaphaël Bonnet, Marielle Nebout, Carine Brousse, et al.
Oncogene|June 26, 2002
Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effectorValère Busuttil, Virginie Bottero, Catherine Frelin, et al.
Nature Communications|September 27, 2016
Structure-function insights reveal the human ribosome as a cancer target for antibioticsAlexander G Myasnikov, S Kundhavai Natchiar, Marielle Nebout, et al.
Leukemia & Lymphoma|June 24, 2017
Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cellsVéronique Imbert, Marielle Nebout, Didier Mary, et al.
Pageof 3